Corona_Virus_Flickr_1.jpg
© National Institute of Allergy and Infectious Diseases-Rocky Mountain Laboratories, NIH
,
Back
Science / January 19, 2022

📺 What you need to know about Omicron

Does the booster shot protect against Omicron? Are there warning signs that point to a potentially severe progression? What is known about Long COVID, and which drugs help best after an infection? MDC molecular biologist Dr. Emanuel Wyler answers these and other questions on Twitter – and in our video right here.
© Felix Petermann, MDC

In part 7 of our series, MDC molecular biologist Emanuel Wyler from Markus Landthaler's lab tackles the question of which area of corona drug discovery still has room for improvement.

© Felix Petermann, MDC

In part 6 of our series, molecular biologist Dr. Emanuel Wyler from the Markus Landthaler lab focuses on antibody-therapy and dexamethasone. Do antibodies help against #omicron? How does dexamethasone work?


 

© Felix Petermann, MDC

In part 5 of our series, molecular biologist Dr. Emanuel Wyler from the Markus Landthaler lab talks to us about Paxlovid. When should it be taken – and can it be used preemptively in certain scenarios? 

© Felix Petermann, MDC

In part 4 of our series, molecular biologist Dr. Emanuel Wyler from the Markus Landthaler lab explains what LongCovid is and what researchers know about it so far. Can a vaccination help to prevent it?

© Felix Petermann, MDC

Researcher Dr. Emanuel Wyler works in the lab of Prof. Markus Landthaler, at the MDC's Berlin-Mitte location. In this short interview series, he answers questions surrounding COVID-19 and SARS-CoV-2. Today: Omicron and the booster shot.

Researcher Dr. Emanuel Wyler works in the lab of Prof. Markus Landthaler, at the MDC's Berlin-Mitte location. In this short interview series, he answers questions surrounding COVID-19 and SARS-CoV-2. Today: the stages of the disease and when it is time to seek medical advice.

Researcher Dr. Emanuel Wyler works in the lab of Prof. Markus Landthaler, at the MDC's Berlin-Mitte location. In this short interview series, he answers questions surrounding COVID-19 and SARS-CoV-2. Today: COVID-19 and vaccination in children. What should parents pay attention to?

Related news & events

scientific image
© Ariana Rauch, Max Delbrück Center
Press Release No. 28

Gut microbiome influences location of immune cells

Researchers at the Experimental and Clinical Research Center of Max Delbrück Center and Charité – Universitätsmedizin Berlin have found that microbial communities in the mouse GI tract are unevenly distributed, which influences immune cell populations. The work was published in “Gut Microbes.”
scientific image

Wissenschaftler*innen haben ein Zwischenprodukt eines Serotoninrezeptors 5-HT3A identifiziert (blau). In der engültigen Form kommt eine fünfte Untereinheit dazu (grün). Das Zwischenprodukt könnte eine neue Zielstruktur für Medikamente sein.

© Max Delbrück Center
Press Release No. 27

A new drug target for psychiatric disorders

Misha Kudryashev’s lab at the Max Delbrück Center has identified a molecular intermediate of a serotonin receptor that is involved in diseases such as depression and schizophrenia. Published in “The EMBO Journal,” the study points to a potentially new target for therapeutics.
scientific image
Press Release No. 25

New clues on how the heart makes arteries

A team in the labs of Holger Gerhardt and Norbert Hübner at the Max Delbrück Center has elucidated how new arteries form, potentially helping to improve therapies aimed at regenerating heart muscle after a heart attack or stroke. The research was published in “Circulation Research.”
David Ausserhofer, Helmholtz
Science

“We want to set an example”

Helmholtz is aiming to become climate-neutral by 2035; construction and building are critical levers in achieving this goal. The “Helmholtz Climate-Friendly Construction” Expertise Network, based at the Max Delbrück Center, aims to make a significant contribution. An interview with Christian Langfeld.